About EnzBond

EnzBond is led by the scientist with a passion for enzymology, science and an urge to transform the world for the better. EnzBond's founding team created the technology in 2016 within the halls of Oxford while pursuing their doctorates. Since then, EnzBond has demonstrated the technology across a wide verity of the enzyme classes and has expanded the technology to include an artificial intelligence backbone to predict thermal stability changes and a throughput that is currently unmatched.

Management Board

Dr Alina Rakhimova

CEO & Co-Founder

Alina holds a PhD in Biochemistry from Oxford University. She has more than 9 years of research experience in the fields of biochemistry and molecular biology. Prior to PhD Alina was a member of the management team of one of the top tech start-ups in Russia.

Dr Robert Simion

CTO & Co-Founder

Robert holds a PhD in Organic Chemistry from Oxford University. He has more than 8 years of research experience with main focus on computational and organic chemistry. Robert has published several peer-reviewed papers and has consulted for companies within biotechnology.

Lachlan Mackinnon

Non-executive Director

Lachlan holds a MSc in Chemistry from Oxford University. He has a wide expertise in growing high-tech start-up companies. Lachlan is a principal at Oxford Sciences Innovation (OSI) and represents OSI on the board of EnzBond.

Advisory Board

Dr Chris Martin


Dr. Chris Martin is a Director and Collaboration Manager for ADC Therapeutics. Previously Dr. Martin was co-founder of Spirogen Ltd and its CEO leading up to the sale of Spirogen to AstraZeneca in October 2013. He has also co-founded Xenova Ltd where he led investments in biotech and technology companies.

Prof Steve Davies


Prof. Steve Davies is the Waynflete Professor of Chemistry and former Head of Department at the University of Oxford. Steve has had an illustrious career in academia and out, with several hundred peer-reviewed publications and several AIM listed spin-outs.

Prof Garrett Morris


Prof. Garrett M. Morris is the Associate Professor of Systems Approaches to Biomedicine in the Department of Statistics at the University of Oxford. Garrett is the co-creator of one of the most highly cited protein-ligand docking tools, AutoDock. His research interests include methods development in computer-aided drug discovery, machine learning, cloud computing, and protein engineering.